CONTI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 1.946
EU - Europa 1.416
AS - Asia 674
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
SA - Sud America 2
AF - Africa 1
Totale 4.045
Nazione #
US - Stati Uniti d'America 1.897
CN - Cina 416
IE - Irlanda 344
SE - Svezia 263
FI - Finlandia 238
DE - Germania 193
UA - Ucraina 187
SG - Singapore 124
TR - Turchia 124
IT - Italia 76
CA - Canada 49
GB - Regno Unito 39
AT - Austria 38
BE - Belgio 17
NL - Olanda 10
RO - Romania 6
EU - Europa 4
IN - India 4
AU - Australia 2
CL - Cile 2
HK - Hong Kong 2
LU - Lussemburgo 2
BD - Bangladesh 1
CZ - Repubblica Ceca 1
ES - Italia 1
HU - Ungheria 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
SC - Seychelles 1
Totale 4.045
Città #
Chandler 415
Dublin 344
Jacksonville 302
Dearborn 158
Izmir 119
Ashburn 105
Boardman 93
Singapore 85
Nanjing 79
Ann Arbor 78
Beijing 74
San Mateo 72
Princeton 70
Wilmington 48
Shanghai 46
Toronto 44
Vienna 38
Bremen 36
Helsinki 29
Nanchang 26
Parma 26
Hebei 25
Jiaxing 20
Des Moines 19
Jinan 18
Shenyang 18
Brussels 17
Kunming 15
New York 14
Hefei 13
Santa Clara 13
Woodbridge 10
Changsha 9
Seattle 9
Dallas 8
Houston 8
Norwalk 8
Tianjin 8
Trezzano Sul Naviglio 8
Coventry 7
Mestre 6
Grafing 5
Taiyuan 5
Tappahannock 5
Auburn Hills 4
Düsseldorf 4
Falls Church 4
Xian 4
Kocaeli 3
Lanzhou 3
Los Angeles 3
Ottawa 3
Taizhou 3
Udine 3
Wuhan 3
Zhengzhou 3
Baotou 2
Bologna 2
Borås 2
Chengdu 2
Chicago 2
Fairfield 2
Florence 2
Focsani 2
Fremont 2
Guangzhou 2
Hangzhou 2
Hong Kong 2
Huizen 2
London 2
Luxembourg 2
Messina 2
Milan 2
Ningbo 2
Pune 2
Rockville 2
Sydney 2
Timisoara 2
Augusta 1
Bellante 1
Bolzano 1
Boston 1
Brescia 1
Brno 1
Budapest 1
Castelnuovo Rangone 1
Catania 1
Dalseong-gun 1
Fuzhou 1
Geislingen an der Steige 1
Haikou 1
Harbin 1
Lhasa 1
Madrid 1
Montreal 1
Mountain View 1
Nuremberg 1
Old Bridge 1
Phoenix 1
Quzhou 1
Totale 2.661
Nome #
Inhibition of human and avian type A Influenza virus multiplication by NEK-2 treatment 126
Antibodies as a source of anti-infective peptides: an update 81
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 80
Great reduction of human and avian type A Influenza virus multiplication by MESNA ( sodium-2 mercaptoethanesulfonate ) treatment. 78
Inibizione della replicazione di virus influenzali mediante trattamento di cellule infette con un peptide sintetico killer 75
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali 73
Peptides from the inside of the antibodies are active against infectious agents and tumours 72
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 71
Inhibition by prostaglandin PGA1 on the multiplication of influenza virus is a dose-dependent effect 70
Inhibition of multiplication of RNA genome containing viruses performed by different concentrations of MESNA. 69
Abortive replication of influenza A viruses in HeLa 229 cells 69
Detection of IgA and IgM antibodies to HIV-1 in neonates by radioimmune western blotting. 69
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali aviari ed umani. 68
Inhibition of multiplication of RNA genome-containing viruses performed by differentconcentrations ofMESNA 68
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 66
Biological characterization of FPV, Ulster 73, replicative cycle. 66
The use of radioimmune western blotting to evaluate indeterminate western blotting results in blood donor HIV serodiagnosis 65
Spettro d'azione universale di mimotopi killer antifungini 64
Determinazione di anticorpi anti-HIVmediante un sistema modificato di immunoblotting 64
Aspetti epidemiologici delle batteriemie in Italia: osservazioni effettuate presso il Laboratorio di Microbiologia di Parma 64
Defective insertion of haemagglutinin as a cause of abortivity of influenza A viruses in HeLa 229 cells. 64
Restriction of A/WSN/33 influenza virus multiplication by prostaglandin PGJ2 64
Improved immunoblotting for the detection and quantitative analysis of antibodies to human immunodeficiency virus. 63
Physical characterization of N4-coded messenger RNA 63
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 63
Inhibition of production of Influenza A viral particles induced by PGA1 treatment 61
USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT. 60
Chromomycin A3 inhibits influenza a virus multiplication in chick embryo fibroblast cells 60
Control of influenza virus polypeptide synthesis 60
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT Description not available for EP1596851 (A1) Description of corresponding document: WO2004069235 (A1) 60
Great reduction of human and avian type A Influenza virus multiplication by MESNA ( sodium-2 mercaptoethanesulfonate ) treatment 59
Restriction of Influenza virus multiplication induced by PK peptide treatment 58
Inibizione della migrazione della emoagglutinina HA del virus Ulster 73 indotta dalla prostaglandina PGA1 57
Effect of coumermycin on influenza A virus replicative cycle. 57
Cerulenin inhibits production of mature virion particles in chick embryo fibroblasts infected by influenza A viruses. 56
Inhibition of late influenza virus genome expression by diamidinophenylindole. 56
ROLE OF ACYLATION OF VIRAL HAEMAGGLUTININ DURING THE INFLUNZA VIRUS INFECTIOUS CYCLE 55
ABORTIVE REPLICATION OF INFLUENZA A VIRUSES IN HELA 229 CELLS 54
INHIBITION OF HUMAN AND AVIAN TYPE A INFLUENZA VIRUS MULTIPLICATION PERFORMED BY MESNA. 54
Inhibition of human and avian type A Influenza virus multiplication performed by MESNA 54
CERULENIN INHIBITS THE PRODUCTION OF MATURE VIRION PARTICLES IN CHICK EMBRYO FIBROBLASTS INFECTED BY INFLUENZA A VIRUSES 53
Sepsi da catetere venoso centrale in corso di insufficienza renale. Aspetti epidemiologici e clinici. 53
Inibizione della migrazione della emoagglutininaHA del virus influenzale umano WSN/33,H1N1,indotta dalla prostaglandina PGJ2 52
Inhibition of multiplication of RNA genome containing viruses performed by different concentrations of MESNA. 52
Indagine epidemiologica dei microrganismi responsabili di infezioni nosocomiali caratterizzate da batteriemie e/o fungiemie 52
Modification of cytoskeleton and prosome networks in relation to protein synthesis in influenza A virus-infected LLC-MK2 cells 52
Batteriemie da germi anaerobi 52
Different patterns of replication in influenza virus-infected KB cells 51
RIWB in comparison with conventional WB, second and third generation ELISA assays for the serodiagnosis of HIV infection 51
Inhibitory effect of diamidinophenylindole on the replication of influena virus in permissive cellular host. 51
Therapeutic Activity of an Anti Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 50
Different patterns of replication in influenza virus-infected KB cells 50
Macromolecular synthesis during abortive infection of KB cells by influenza virus 50
Restriction of Influenza virus multiplication induced by treatment with a yeast killer toxin-like synthetic peptide 49
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 49
Viral protein synthesis during replication of bacteriophage T1. 49
Role of acylation of viral haemagglutinin during the influenza virus infectious cycle 49
Phosphorylation of viral polypeptides in cells infected with influenza virus 49
Radioimmune western blotting in comparison with conventional western blotting, second and third generation ELISA assays for the serodiagnosis of HIV-1 infection. 49
Migration of influenza virus-specific polypeptides from cytoplasm to nucleus of infected cells. 48
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT. 47
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT 46
Inibizione della moltiplicazione del virus influenzale umano WSN/33,H1N1,indotta dalla prostaglandina PGA1:effetto dose-dipendente 45
Effetto di PGA1 e PGJ2 sulla replicazione del virus influenzale 43
GREAT REDUCTION OF HUMAN AND AVIAN TYPE A INFLUENZA VIRUS MULTIPLICATION BYMELITTIN TREATMENT 43
Inhibition of multiplication of RNA genome- containing viruses performed by different concentrations of MESNA. 40
Synthesis of stable RNA in "Escherichia coli" cells infected with N4. 38
INHIBITION OF LATE INFLUENZA VIRUS GENOME EXPRESSION BY DIAMIDINEPHENILINDOLE 37
Radio immune Western blotting: a possible solution to indeterminate conventional Western blotting results for the serodiagnosis of HIV infections. 36
Il significato delle colture intraoperatorie della parete e del trombo negli interventi per aneurisma dell'aorta addominale 36
Totale 4.058
Categoria #
all - tutte 14.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.441


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020581 0 0 0 14 102 98 143 18 46 77 15 68
2020/2021410 5 70 25 1 69 6 33 5 102 7 77 10
2021/2022339 4 3 2 17 18 11 48 56 20 36 24 100
2022/20231.389 130 129 77 131 136 180 4 95 458 7 26 16
2023/2024339 22 37 5 8 34 76 31 26 12 8 33 47
2024/2025196 17 83 89 7 0 0 0 0 0 0 0 0
Totale 4.058